CVRx, Inc. (CVRX) has released its preliminary results, projecting a growth rate of 35% for the fourth quarter and 30% for the entire year of 2024.
For Q4, the medical device manufacturer anticipates generating between $15.2 million and $15.3 million in revenue. The projected revenue for the full year of 2024 ranges from $51.1 million to $51.2 million.
Looking forward, the company forecasts its total revenue for fiscal year 2025 to be in the range of $63.0 million to $65.0 million. For the first quarter of 2025, expected revenue is set between $14.5 million and $15.0 million.
Presently, CVRx's stock stands at $14.69, reflecting a 3.71% increase on the Nasdaq.
